In a randomized clinical trial including 50 physicians, the use of an LLM did not significantly enhance diagnostic reasoning performance compared with the availability of only conventional resources. Fifty physicians (26 attendings, 24 residents; median years in practice, 3 [IQR, 2-8]) participated virtually as well as at 1 in-person site. The median diagnostic reasoning score per case was 76% (IQR, 66%-87%) for the LLM group and 74% (IQR, 63%-84%) for the conventional resources-only group, with an adjusted difference of 2 percentage points (95% CI, ?4 to 8 percentage points; P?=?.60). The median time spent per case for the LLM group was 519 (IQR, 371-668) seconds, compared with 565 (IQR, 456-788) seconds for the conventional resources group, with a time difference of ?82 (95% CI, ?195 to 31; P?=?.20) seconds. The LLM alone scored 16 percentage points (95% CI, 2-30 percentage… 

The use of genomic testing in clinical practice, once thought to be a distant goal, is now a reality that is profoundly impacting medicine. This special issue of the Association for Diagnostics & Laboratory Medicine’s (ADLM’s, formerly AACC’s) Clinical Chemistry journal spotlights the breaking research from laboratory medicine experts that is driving this field forward — and that is set to transform diagnosis and care for medical conditions across the board. Clinical genomics uses testing to learn about a person’s genetic make-up in order to help predict, prevent, diagnose, and treat disease. This field has advanced dramatically over the past few decades thanks to developments in genomic sequencing technologies and bioinformatics, and an ever-deepening understanding of the human genome. Maternal-fetal medicine is one area in particular where these advances are significantly improving care. Cell-free DNA testing has already made it… 

A new study shows that genetic testing could be used to determine which drugs will — and won’t — work for patients with Candida auris (C. auris), a multidrug-resistant yeast that causes life-threatening disease. These findings could improve treatment for C. auris infections by enabling patients to start taking effective antifungal agents sooner. The study was published today in a special issue of the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) Clinical Chemistry journal titled „Genomics: Current & emerging trends in the clinical laboratory.“ Since C. auris was identified in 2009, this pathogenic fungus has spread worldwide, causing severe illness in patients in healthcare facilities. Not only is it deadly, with an estimated mortality rate ranging from 30%-60%, but it is also particularly challenging to treat. One of the major reasons for this is that there are many different… 

LabNews Media LLC plant für 2025 die Einführung eines eigenen Kryptowährungstokens, der das Unternehmen in die digitale Zukunft führen soll[1]. Das unabhängige Medienunternehmen, das sich auf analytische, biotechnologische und laborwissenschaftliche Nachrichten spezialisiert hat, zielt darauf ab, seine verschiedenen Portale wie labnews.ai/ und Pugnalom.io durch diese Blockchain-Technologie enger zu vernetzen[1][3]. Der Token soll als Brücke zwischen den verschiedenen Content-Plattformen des Unternehmens dienen und den Nutzern Zugang zu Premium-Inhalten sowie Belohnungen für aktive Beteiligung ermöglichen[1]. Diese Initiative erfolgt in einer Zeit, in der die Tokenisierung von realen Vermögenswerten stark an Bedeutung gewinnt. Experten prognostizieren für den Tokenisierungsmarkt ein Wachstum auf 2 bis 30 Billionen Dollar in den nächsten fünf Jahren[7]. Die Entscheidung von LabNews Media LLC, in den Kryptowährungsmarkt einzusteigen, spiegelt einen breiteren Trend wider, bei dem Medienunternehmen zunehmend Blockchain-Technologien nutzen, um ihre Nutzereinbindung zu verstärken und neue Einnahmequellen zu erschließen[1]. Während…